| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q2 2024 |
Q3 2024 |
| Common Stock, Shares, Issued |
5,709,500 |
shares |
0% |
Q2 2024 |
Q3 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q3 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$13,242 |
USD |
-67% |
Q2 2024 |
Q3 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2024 |
Q3 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q3 2024 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q2 2024 |
Q3 2024 |
| Additional Paid in Capital |
$261,161 |
USD |
94% |
Q2 2024 |
Q3 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q3 2024 |
| Share-based Payment Arrangement, Expense |
$629,774 |
USD |
189% |
Q2 2024 |
Q3 2024 |
| Interest Expense |
$220,050 |
USD |
|
Q2 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q3 2024 |